Matthew Winkler's most recent trade in Akoya Biosciences Inc was a trade of 984,513 Common Stock done . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akoya Biosciences Inc | Matthew Winkler | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 984,513 | 0 | - | - | Common Stock | |
| Akoya Biosciences Inc | Matthew Winkler | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 56,322 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Matthew Winkler | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 50,000 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Matthew Winkler | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 30,549 | 0 | - | - | Stock Option (right to buy) | |
| Akoya Biosciences Inc | Matthew Winkler | Director | Other type of transaction at price $ 0.00 per share. | 08 Jul 2025 | 16,860 | 0 | - | - | Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Matthew Winkler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Matthew Winkler | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 203,388 | 984,513 | - | 5 | 1,016,940 | Common Stock |
| Akoya Biosciences Inc | Matthew Winkler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Akoya Biosciences Inc | Matthew Winkler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Akoya Biosciences Inc | Matthew Winkler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 16,860 | 16,860 | - | - | Stock Option (Right to Buy |